Does Zembrace Stop Migraine Pain?
Zembrace SymTouch (sumatriptan 3 mg injection) stops or reduces migraine pain in many patients by constricting blood vessels in the brain and blocking pain signals. Clinical trials showed 66-70% of patients had no or mild pain 2 hours after a 6 mg dose (the standard dose, though Zembrace is 3 mg for rapid relief), compared to 17-29% on placebo.[1][2]
How Quickly Does It Work?
Pain relief starts within 10-15 minutes for many, peaking at 30-60 minutes. About 58% report relief at 30 minutes with the 3 mg dose, faster than oral triptans due to injection delivery.[1][3]
How Effective Is It Compared to Other Triptans?
Zembrace matches or exceeds Imitrex (sumatriptan injection) in speed and efficacy, with similar 2-hour pain-free rates (65-70%). It's designed for quicker injection and less volume, aiding those with nausea or severe attacks.[2][4] Against newer options like Ubrelvy (ubrogepant), Zembrace acts faster but may have more vascular side effects.[5]
What If It Doesn't Stop the Pain?
If no relief after 2 hours or pain recurs within 24 hours, a second dose (max 12 mg/day) can be tried. Up to 40% need retreatment. It's not for non-migraine headaches or cluster headaches.[1][3]
Common Side Effects and Risks
Injection site reactions (pain, redness) hit 59% of users. Other issues include chest tightness (5-10%), dizziness, or drowsiness. Avoid if you have heart disease, uncontrolled hypertension, or use MAOIs—risk of heart attack or stroke exists.[1][6] No patent data limits generics yet; exclusivity ended in 2021.[7]
[1]: Zembrace Prescribing Information (FDA)
[2]: Promius Pharma Clinical Data
[3]: Sumatriptan Injection Trials (NEJM)
[4]: Imitrex vs Zembrace Comparison (Drugs.com)
[5]: Ubrelvy vs Triptans (Medscape)
[6]: Zembrace Safety Profile (RxList)
[7]: DrugPatentWatch: Zembrace Patents